A healthy prescription for growth

RMB advised Mediclinic on its R3.2-bn capital raising.

RMB advised Mediclinic on an extremely successful R3.2-bn equity capital raising through an Accelerated Bookbuild Offering, following Mediclinic’s R28-bn balance sheet restructuring in 2012. The offering, which closed in under three hours, was significantly oversubscribed, and included substantial participation by local and international investors, allowing Mediclinic to broaden its shareholder base. The transaction highlights the continued strength of RMB, through its RMB Morgan Stanley joint venture, in equity capital markets.